Erythropoietin Suppresses the Hepatic Fibrosis Caused by Thioacetamide: Role of the PI3K/Akt and TLR4 Signaling Pathways

Erythropoietin (EPO) is recognized for its function in erythropoiesis; however, its potential antifibrotic effect against liver fibrosis remains unknown. This study examined whether EPO affects thioacetamide (TAA)-induced liver fibrosis by concentrating on the Toll-like receptor 4 (TLR4) cascade and...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbaset, Marawan A., Mohamed, Bassim M. S. A., Moustafa, Passant E., Mansour, Dina F., Afifi, Sherif M., Esatbeyoglu, Tuba, Abdelrahman, Sahar S. M., Fayed, Hany M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465256/
https://www.ncbi.nlm.nih.gov/pubmed/37649466
http://dx.doi.org/10.1155/2023/5514248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465256/
https://www.ncbi.nlm.nih.gov/pubmed/37649466
http://dx.doi.org/10.1155/2023/5514248

Ejemplares similares